Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant for PONV in Gynecologic Surgery
NCT00888329Phase 4Terminated
- Sponsor
- Mayo Clinic
- Start
- Jul 2007
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of aprepitant in postoperative nausea and vomiting (PONV), sponsored by Mayo Clinic. Primary endpoint: Number of Participants With Emesis at 24 hours. Started Jul 2007; status: terminated.
02
Drugs
aprepitant
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT00888329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00888329.